Gwendolyn Knowlton Binder-scholl - Net Worth and Insider Trading
Gwendolyn Knowlton Binder-scholl Net Worth
The estimated net worth of Gwendolyn Knowlton Binder-scholl is at least $2,960 dollars as of 2024-05-04. Gwendolyn Knowlton Binder-scholl is the Chief Technology Officer of Adaptimmune Therapeutics PLC and owns about 2,487 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $2,960. Details can be seen in Gwendolyn Knowlton Binder-scholl's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gwendolyn Knowlton Binder-scholl has not made any transactions after 2019-01-14 and currently still holds the listed stock(s).
Transaction Summary of Gwendolyn Knowlton Binder-scholl
Gwendolyn Knowlton Binder-scholl Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gwendolyn Knowlton Binder-scholl owns 1 companies in total, including Adaptimmune Therapeutics PLC (ADAP) .
Insider Ownership Summary of Gwendolyn Knowlton Binder-scholl
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2019-01-14 | EVP & Adaptimmune LLC |
Gwendolyn Knowlton Binder-scholl Latest Holdings Summary
Gwendolyn Knowlton Binder-scholl currently owns a total of 1 stock. Gwendolyn Knowlton Binder-scholl owns 2,487 shares of Adaptimmune Therapeutics PLC (ADAP) as of January 14, 2019, with a value of $2,960.
Latest Holdings of Gwendolyn Knowlton Binder-scholl
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2019-01-14 | 2,487 | 1.19 | 2,960 |
Holding Weightings of Gwendolyn Knowlton Binder-scholl
Gwendolyn Knowlton Binder-scholl Form 4 Trading Tracker
According to the SEC Form 4 filings, Gwendolyn Knowlton Binder-scholl has made a total of 0 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 1,514 shares on January 14, 2019, which brought Gwendolyn Knowlton Binder-scholl around $8,130.
Insider Trading History of Gwendolyn Knowlton Binder-scholl
- 1
Gwendolyn Knowlton Binder-scholl Trading Performance
Gwendolyn Knowlton Binder-scholl Ownership Network
Gwendolyn Knowlton Binder-scholl Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Gwendolyn Knowlton Binder-scholl is the EVP & Adaptimmune LLC of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Gwendolyn Knowlton Binder-scholl made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 115,184 shares made by Adrian Rawcliffe , a net sale of 48,376 shares made by John Lunger , and a net sale of 46,074 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
Gwendolyn Knowlton Binder-scholl Mailing Address
Above is the net worth, insider trading, and ownership report for Gwendolyn Knowlton Binder-scholl. You might contact Gwendolyn Knowlton Binder-scholl via mailing address: 1903 Carpenter Street, Philadelphia Pa 19146.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
